Headquartered in Richmond, VA Fiscal year ends December NYSE: MO altria.com
Altria Group sells nicotine products to U.S. adult consumers age 21+ through wholly owned subsidiaries:
- Philip Morris USA: Marlboro, Virginia Slims, Parliament, L&M and Basic cigarettes.
- John Middleton Co.: Black & Mild machine-made large cigars.
- U.S. Smokeless Tobacco Company: Copenhagen and Skoal moist smokeless tobacco.
- Helix Innovations: on! and on! PLUS oral nicotine pouches.
- NJOY: e-vapor products.
It reports two segments. Smokeable products covers combustible cigarettes and cigars, including contract-manufactured export cigarettes for third parties. Oral tobacco products covers moist smokeless tobacco and nicotine pouches. NJOY, Horizon Innovations (a majority-owned heated tobacco joint venture), Helix International and R&D activities sit in 'All Other.'
Altria also holds equity-method investments in Anheuser-Busch InBev and Cronos Group, both reported on a one-quarter lag. Its stated 'Moving Beyond Smoking' Vision is to transition adult smokers to smoke-free alternatives and explore growth beyond the U.S. and beyond nicotine. The business is highly cash generative and returns capital through a progressive dividend and share repurchases. Updated
Altria just set a fresh one-year high at $78.67, topping its October 30 peak by 0.82%. Competitor Philip Morris International rose 1.19% the same day.
Moves: Nov 13, 2026 · Alpha Vantage daily close
1 has no US listing
Altria notched a new 52-week high at $76.75, 0.89% above the peak it set just a week ago, after its Q3 earnings beat. The defensive dividend name is now doing growth-stock work.
In smokeable products, PM USA grew operating companies income through its data-driven, total portfolio approach, with Cowboy Cut strengthening Marlboro's premium position and Basic continuing to gain share in discount. In smoke-free, Helix made meaningful progress by expanding on! PLUS 12-milligram nationwide, investing in brand-building initiatives and preparing for its next wave of innovation, which is now underway with the introduction of Blueberry Mint and Mango Pineapple flavor extensions…
Altria is defending both ends of the cigarette aisle at once, pushing Marlboro premium with Cowboy Cut while Basic takes discount share from trade-down smokers. On the smoke-free side, ON! PLUS 12-milligram is going nationwide with two new flavors, Altria's answer to higher-strength pouch rivals.
Altria delivered strong financial performance in the third quarter, growing adjusted diluted earnings per share by 4.8%, while continuing to invest in our Vision and building on our foundation for the future.
Shrinking cigarette volumes still aren't stopping Altria's earnings engine, and Mancuso is leaning on pricing and buybacks to keep the per-share line moving while the smoke-free pivot plays out. For a $121.9 billion dividend holding, that steady compounding is the whole thesis.
Altria raised full-year adjusted EPS guidance to $5.66 to $5.74 even as domestic cigarette shipments fell an estimated 4%. Marlboro retail share slipped and pouch brand on! lost ground, so the earnings growth is leaning on levers outside the core brands.
Our strong performance through the first nine months and confidence in our full-year plan allowed us to raise our earnings guidance for the year. We now expect to deliver adjusted diluted EPS in a range of $5.66 to $5.74, representing a growth rate of 4.5% to 6.0% from a base of $5.42 in 2025.
Altria is lifting its full-year earnings outlook with one quarter left, a rare move for a shrinking-volume cigarette business funding a 7%-plus dividend. The raise puts growth at the upper end of management's long-term algorithm, and income investors get the payout coverage question answered for 2026.
Our highly cash-generative businesses supported significant returns to shareholders through dividends and share repurchases, while we continued to invest in support of our Vision. In August, we announced our 61st dividend increase in 57 years, and our Board of Directors (Board) recently authorized a $1 billion expansion of our existing share repurchase program.
Altria's board just added $1 billion to the repurchase authorization, stacking buybacks on top of a dividend the company has raised 61 times in 57 years. For income holders, the cash return engine is still intact heading into 2027.
Altria just set a fresh 52-week high at $73.84, a level it has not touched since climbing from the low-$53s a year ago.
Smokers are quitting, yet two tobacco giants keep raising payouts. One has a Dividend King record, the other pays in a currency that swings every quarter. Which income stock handles the shrinking…
Treasuries now pay 5.1% with zero equity risk, so dividend stocks have to earn their place in an income portfolio. Five payers pass a stricter test than yield alone, and one of…
A deposit lands every month, but the amounts swing by nearly four times from the smallest check to the largest. Before you build a retirement budget around this fund, see what drives…
Four fat-yield stocks hand the IRS a slice of your income every single year, and the bite grows with your bracket. One account choice decides how much of that payout you keep,…
A Dividend King’s yield usually rises for an uncomfortable reason: the share price falls while the payout keeps growing. When a long run and a high yield show up together, the first…
Two tobacco giants pay out nearly identical shares of their earnings, yet one yields almost twice as much as the other. For retirees choosing between them, the real question is what each…
The highest-yielding stock in this six-stock dividend portfolio is not the one costing you the most at tax time. Find out which holding triggers the biggest bill, and why where you park…
Four stocks yielding close to 6% each have rallied hard in 2026, yet income investors keep holding on. Before you buy, one carries a 78% payout with missing cash flow data and…
When a dividend gets cut, lenders usually see trouble first. Four payers yielding above 5% span telecom, tobacco, real estate, and logistics, yet one of them runs a coverage cushion so thin…
Six household income stocks pay yields above 5%, and most just raised guidance. Yet debt loads, tenant concentration, and negative equity hide beneath the payouts. Which dividends have the cash to survive,…
One of these four high-yield dividend payers earns less than it hands out, while another faces a wildfire liability nobody can price. Before you build a retirement paycheck around them, find out…
Six high-yield holdings can turn a Roth IRA into a tax-free paycheck, but one fund's payout is almost entirely return of capital and another dividend vanished for over a year. Can you…
Six household-name dividend payers hand you a steady paycheck, but one of them gets taxed far harder than the other five. Find out which holding belongs in a Roth first, and how…
Two of the six stocks in this high-yield portfolio quietly drive most of the IRS bill, and a simple change in where you hold them could keep that money working for you.…
A fat yield means nothing if the check bounces. Five payers across telecom, tobacco, pharma, real estate and pipelines show how to test coverage, and one of them carries a debt pile…
Altria Group sells nicotine products to U.S. adult consumers age 21+ through wholly owned subsidiaries: - Philip Morris USA: Marlboro, Virginia Slims, Parliament, L&M and Basic cigarettes. - John Middleton Co.: Black & Mild machine-made large cigars. - U.S.
24/7 Wall St.'s 12-month price target for MO is $83.25, rated Buy. The Wall Street consensus target is $73.45. MO price prediction →
